Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pepcid AC Gelcaps Sample Pouch Deferral Granted Without "Drug Facts" Title

This article was originally published in The Tan Sheet

Executive Summary

J&J/Merck's request for a nine-month deferral from complying with the OTC labeling format for sample pouches of the company's H2 antagonist Pepcid AC Gelcaps has been granted.
Advertisement

Related Content

OTC Labeling Rule General Deferral For Convenience-Size Drugs To Be Issued
OTC Labeling Rule General Deferral For Convenience-Size Drugs To Be Issued
OTC Labeling Rule General Deferral For Convenience-Size Drugs To Be Issued
McNeil “Drug Facts” Booklet Pouch Labeling Proposed For Two-Count Sizes
Block Exemption Request Differentiates "Label" From "Labeling"
OTC Labeling Exemption, Deferral Timelines Depend On Complexity - FDA
Whitehall-Robins Chap Stick Labeling Exemption Request Denied
OTC Labeling Implementation Date Extended One Year
Pepcid AC Gelcaps OTC Labeling Exemptions Sought By J&J/Merck
Pepcid AC Gelcaps OTC Labeling Exemptions Sought By J&J/Merck

Topics

Advertisement
UsernamePublicRestriction

Register

PS091159

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel